Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

Nathan K LeBrasseur, Meghan Kelly, Tsu Shuen Tsao, Stephen R. Farmer, Asish K. Saha, Neil B. Ruderman, Eva Tomas

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARγ in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARγ-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 μM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 μM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-D-glucose uptake and the oxidation of exogenous [ 14C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARγ to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARγ-mediated gene transcription.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume291
Issue number1
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

troglitazone
Thiazolidinediones
AMP-Activated Protein Kinases
Peroxisome Proliferator-Activated Receptors
Tissue
Transcription
Muscle
Genes
pioglitazone
Muscles
Rats
Skeletal Muscle
Insulin
Adipogenesis
Time and motion study
Adipokines
Palmitates
Adiponectin
Deoxyglucose
Adenosine Monophosphate

Keywords

  • Acetyl-coenzyme A carboxylase
  • Adiponectin
  • Diabetes
  • Insulin sensitivity
  • Metabolism

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. / LeBrasseur, Nathan K; Kelly, Meghan; Tsao, Tsu Shuen; Farmer, Stephen R.; Saha, Asish K.; Ruderman, Neil B.; Tomas, Eva.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 291, No. 1, 2006.

Research output: Contribution to journalArticle

LeBrasseur, Nathan K ; Kelly, Meghan ; Tsao, Tsu Shuen ; Farmer, Stephen R. ; Saha, Asish K. ; Ruderman, Neil B. ; Tomas, Eva. / Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. In: American Journal of Physiology - Endocrinology and Metabolism. 2006 ; Vol. 291, No. 1.
@article{c61814b84f2449db8f97e5dd5d6e347c,
title = "Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues",
abstract = "Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARγ in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARγ-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 μM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 μM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-D-glucose uptake and the oxidation of exogenous [ 14C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARγ to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARγ-mediated gene transcription.",
keywords = "Acetyl-coenzyme A carboxylase, Adiponectin, Diabetes, Insulin sensitivity, Metabolism",
author = "LeBrasseur, {Nathan K} and Meghan Kelly and Tsao, {Tsu Shuen} and Farmer, {Stephen R.} and Saha, {Asish K.} and Ruderman, {Neil B.} and Eva Tomas",
year = "2006",
doi = "10.1152/ajpendo.00453.2005",
language = "English (US)",
volume = "291",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

AU - LeBrasseur, Nathan K

AU - Kelly, Meghan

AU - Tsao, Tsu Shuen

AU - Farmer, Stephen R.

AU - Saha, Asish K.

AU - Ruderman, Neil B.

AU - Tomas, Eva

PY - 2006

Y1 - 2006

N2 - Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARγ in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARγ-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 μM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 μM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-D-glucose uptake and the oxidation of exogenous [ 14C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARγ to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARγ-mediated gene transcription.

AB - Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARγ in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARγ-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 μM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 μM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-D-glucose uptake and the oxidation of exogenous [ 14C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARγ to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARγ-mediated gene transcription.

KW - Acetyl-coenzyme A carboxylase

KW - Adiponectin

KW - Diabetes

KW - Insulin sensitivity

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=33745869049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745869049&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00453.2005

DO - 10.1152/ajpendo.00453.2005

M3 - Article

C2 - 16464908

AN - SCOPUS:33745869049

VL - 291

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 1

ER -